| 12/12/13 | 07:00:09 | 12 Dec 2013 | | FDA Advisory Committee Votes on Metreleptin | RNS |
| 06/12/13 | 07:00:13 | 6 Dec 2013 | | European Commission Approves Fluenz Tetra | RNS |
| 02/12/13 | 15:00:27 | 2 Dec 2013 | | Blocklisting Interim Review | RNS |
| 02/12/13 | 13:00:02 | 2 Dec 2013 | | Total Voting Rights | RNS |
| 22/11/13 | 13:42:59 | 22 Nov 2013 | | XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETES | RNS |
| 19/11/13 | 07:00:13 | 19 Nov 2013 | | NDA for Naloxegol accepted by US FDA | RNS |
| 01/11/13 | 16:00:01 | 1 Nov 2013 | | Total Voting Rights | RNS |
| 01/11/13 | 13:45:01 | 1 Nov 2013 | | Director/PDMR Shareholding | RNS |
| 31/10/13 | 07:02:01 | 31 Oct 2013 | | US Court Decision in Pulmicort Respules Litigation | RNS |
| 31/10/13 | 07:01:12 | 31 Oct 2013 | | Marc Dunoyer Appointed Chief Financial Officer | RNS |
| 31/10/13 | 07:00:26 | 31 Oct 2013 | | 3rd Quarter Results | RNS |
| 30/10/13 | 09:00:02 | 30 Oct 2013 | | Notice of Results | RNS |
| 30/10/13 | 07:00:10 | 30 Oct 2013 | | ASTRAZENECA ADVANCES BENRALIZUMAB TO PHASE III | RNS |
| 22/10/13 | 08:00:09 | 22 Oct 2013 | | AstraZeneca starts phase III study for selumetinib | RNS |
| 15/10/13 | 08:00:20 | 15 Oct 2013 | | Medimmune acquires Spirogen | RNS |
| 07/10/13 | 08:00:07 | 7 Oct 2013 | | MedImmune completes Amplimmune acquisition | RNS |
| 01/10/13 | 17:00:02 | 1 Oct 2013 | | Total Voting Rights | RNS |
| 30/09/13 | 08:01:46 | 30 Sept 2013 | | MAA FOR OLAPARIB ACCEPTED BY EMA | RNS |
| 27/09/13 | 08:00:20 | 27 Sept 2013 | | MAA APPLICATION FOR NALOXEGOL ACCEPTED | RNS |
| 20/09/13 | 13:54:11 | 20 Sept 2013 | | Fluenz Tetra receives positive CHMP opinion in EU | RNS |
| 04/09/13 | 08:00:09 | 4 Sept 2013 | | Starts phase III clinical programme for olaparib | RNS |
| 02/09/13 | 16:00:02 | 2 Sept 2013 | | Total Voting Rights | RNS |
| 27/08/13 | 08:00:20 | 27 Aug 2013 | | MEDIMMUNE ACQUIRES AMPLIMMUNE | RNS |
| 01/08/13 | 17:00:03 | 1 Aug 2013 | | Total Voting Rights | RNS |
| 01/08/13 | 16:00:03 | 1 Aug 2013 | | Director/PDMR Shareholding | RNS |
| 01/08/13 | 08:00:34 | 1 Aug 2013 | | Half Yearly Pipeline Update | RNS |
| 01/08/13 | 08:00:23 | 1 Aug 2013 | | Half Yearly Report | RNS |
| 31/07/13 | 10:00:04 | 31 Jul 2013 | | Notice of Results | RNS |
| 31/07/13 | 08:00:16 | 31 Jul 2013 | | Collaborates with FibroGen on anaemia treatment | RNS |
| 26/07/13 | 08:00:58 | 26 Jul 2013 | | FDA receipt of dapagliflozin resubmission | RNS |
| 19/07/13 | 08:00:06 | 19 Jul 2013 | | AstraZeneca completes acquisition of Omthera | RNS |
| 15/07/13 | 08:00:04 | 15 Jul 2013 | | Simon Lowth, CFO, to leave AstraZeneca | RNS |
| 11/07/13 | 17:30:05 | 11 Jul 2013 | | Holding(s) in Company | RNS |
| 01/07/13 | 16:00:03 | 1 Jul 2013 | | Total Voting Rights | RNS |
| 28/06/13 | 18:35:01 | 28 Jun 2013 | | Publication of Prospectus | RNS |
| 28/06/13 | 08:00:09 | 28 Jun 2013 | | Completes Acquisition of Pearl Therapeutics | RNS |
| 19/06/13 | 08:00:08 | 19 Jun 2013 | | Announces top-line results for SAVOR study | RNS |
| 12/06/13 | 16:00:02 | 12 Jun 2013 | | Director/PDMR Shareholding | RNS |
| 12/06/13 | 16:00:02 | 12 Jun 2013 | | Director/PDMR Shareholding | RNS |
| 12/06/13 | 16:00:02 | 12 Jun 2013 | | Director/PDMR Shareholding | RNS |
| 10/06/13 | 08:00:12 | 10 Jun 2013 | | To Acquire Pearl Therapeutics | RNS |
| 04/06/13 | 08:00:10 | 4 Jun 2013 | | Top-line results from Phase III Oskira trials | RNS |
| 03/06/13 | 14:00:03 | 3 Jun 2013 | | Blocklisting Interim Review | RNS |
| 03/06/13 | 13:00:04 | 3 Jun 2013 | | Total Voting Rights | RNS |
| 28/05/13 | 08:00:22 | 28 May 2013 | | Appeal against generic PULMICORT RESPULES | RNS |
| 28/05/13 | 08:00:18 | 28 May 2013 | | Acquires Omthera Pharmaceuticals | RNS |
| 14/05/13 | 15:00:01 | 14 May 2013 | | Director/PDMR Shareholding | RNS |
| 08/05/13 | 15:00:04 | 8 May 2013 | | Director/PDMR Shareholding | RNS |
| 08/05/13 | 15:00:04 | 8 May 2013 | | Director/PDMR Shareholding | RNS |
| 02/05/13 | 14:00:05 | 2 May 2013 | | Director/PDMR Shareholding | RNS |
